NR3C2 and acute myocardial infarction: Antithrombotic agents, β-blockers, angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers, Mineralocorticoid receptor antagonist and statins should be given to all patients with acute myocardial infarction, exclusion of contraindications.